A new vaccine has been developed to act as a booster to Bacille Calmette Guerin (BCG), currently the only TB vaccine available. BCG was developed in the 1920s and has been used worldwide.
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Your new post is loading...
Your new post is loading...
|
Link to the Science Translational Medicine publication:
http://stm.sciencemag.org/content/5/205/205ra134
Vol. 5, Issue 205, p. 205ra134
Sci. Transl. Med. DOI: 10.1126/scitranslmed.3006843A Human Type 5 Adenovirus–Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus ImmunityFiona Smaill1,2, Mangalakumari Jeyanathan1,3, Marek Smieja1,2, Maria Fe Medina1,3,Niroshan Thanthrige-Don1,3, Anna Zganiacz1,3, Cindy Yin1,3, Armando Heriazon1,3,Daniela Damjanovic1,3, Laura Puri1, Jemila Hamid1,4, Feng Xie4, Ronan Foley1,3,Jonathan Bramson1,2,3, Jack Gauldie1,2,3 and Zhou Xing1,2,3,*